4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-22-001516
Chief Commercial Officer bought 6,842 shares at $19.00 ($129,998)
- Chief Commercial Officer acquired 28,333 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Olinger Margaret Chief Commercial Officer | 2022-01-06 | Grant or award | +28,333 | 209,916 | D | ||
| Olinger Margaret Chief Commercial Officer | 2022-01-06 | Purchase | +6,842 | $19.00 | $129,998 | 216,758 | D |
| Derivatives | |||||||
| Olinger Margaret Chief Commercial Officer | 2022-01-06 | Grant or award · Stock Option (right to buy) | +127,500 | 127,500 | D | ||
| Open-market purchases · 6,842 sh · avg $19.00 · $129,998 | |||||||
Loading xslF345X03/doc4.xml…